Thursday, February 28, 2019

Olin Corp (OLN) Files 10-K for the Fiscal Year Ended on December 31, 2018

Olin Corp (NYSE:OLN) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Olin Corp is manufactures and sells chlor alkali products. It is engaged in three segments Chlor Alkali Products, Epoxy and Winchester. Olin Corp has a market cap of $4.31 billion; its shares were traded at around $26.05 with a P/E ratio of 13.37 and P/S ratio of 0.63. The dividend yield of Olin Corp stocks is 3.06%. Olin Corp had annual average EBITDA growth of 4.10% over the past ten years. GuruFocus rated Olin Corp the business predictability rank of 3-star.

For the last quarter Olin Corp reported a revenue of $1.6 billion, compared with the revenue of $1.6 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $6.9 billion, an increase of 10.8% from last year. For the last five years Olin Corp had an average revenue growth rate of 28.7% a year.

The reported diluted earnings per share was $1.95 for the year, a decline of 40.2% from the previous year. The Olin Corp had a decent operating margin of 10.07%, compared with the operating margin of 6.04% a year before. The 10-year historical median operating margin of Olin Corp is 9.90%. The profitability rank of the company is 8 (out of 10).

At the end of the fiscal year, Olin Corp has the cash and cash equivalents of $178.8 million, compared with $218.4 million in the previous year. The long term debt was $3.1 billion, compared with $3.6 billion in the previous year. The interest coverage to the debt is 2.9, which is not a favorable level. Olin Corp has a financial strength rank of 5 (out of 10).

At the current stock price of $26.05, Olin Corp is traded at 24.8% discount to its historical median P/S valuation band of $34.63. The P/S ratio of the stock is 0.63, while the historical median P/S ratio is 0.84. The intrinsic value of the stock is $20.87 a share, according to GuruFocus DCF Calculator. The stock lost 18.19% during the past 12 months.

Directors and Officers Recent Trades:

VP & President, Winchester Brett A Flaugher sold 12,500 shares of OLN stock on 02/22/2019 at the average price of $26.53. The price of the stock has decreased by 1.81% since.

For the complete 20-year historical financial data of OLN, click here.

Tuesday, February 26, 2019

Better Buy: Amgen vs. Celgene

If you're looking to invest in successful big biotechs, two of the biggest are Amgen (NASDAQ:AMGN) and Celgene (NASDAQ:CELG). Over the past 10 years, both stocks have more than tripled.  

The two companies are at very different stages right now, though. Amgen is looking to roll out new products to bolster revenue from its older drugs, while Bristol-Myers Squibb could soon acquire Celgene. But which of these two biotech stocks is the better buy right now?

Scientist wearing a mask and holding a test tube with healthcare icons in the foreground

Image source: Getty Images.

The case for Amgen

Let's first address the negatives for Amgen. The company's overall revenue growth has been weak because of headwinds for several of its top-selling products. You can start with Amgen's current No. 1 drug, Enbrel. The drug's sales continue to slide in the face of intense competition in the immunology market. Sales are also declining for blockbuster drugs Neulasta, Aranesp, and Epogen. 

However, Amgen's product lineup includes several drugs that have solid momentum. Osteoporosis drugs Prolia and Xgeva achieved double-digit percentage sales growth last year. Amgen reported in its Q4 results that the launch of new migraine drug Aimovig, which the biotech co-markets with Novartis, is going even better than expected. The biotech also has several other drugs that continue to pick up traction, including cancer therapy Blincyto, multiple myeloma drug Kyprolis, and cholesterol drug Repatha.

Amgen has made a big bet on biosimilars, a bet that is only beginning to pay off. The company's biosimilar to Humira launched in Europe in the fourth quarter of 2018. Amgen also has biosimilars to blockbuster drugs Remicade, Rituxan, and Soliris in development. 

In addition to these biosimilars, Amgen's pipeline features seven late-stage programs. One especially promising candidate is tezepelumab, which Amgen is developing with partner AstraZeneca. The drug is in a phase 3 study targeting the treatment of asthma and a phase 2 study for treating atopic dermatitis. 

Amgen claims a huge cash stockpile of $29.3 billion, including cash, cash equivalents, and marketable securities. The company uses its solid financial position to reward investors with a dividend that currently yields 3.1%.  

The case for Celgene

Are there any negatives for Celgene? Yep. The biotech is highly dependent on blood cancer drug Revlimid, which generates around 63% of Celgene's total revenue. Celgene is also in litigation defending key patents for Revlimid. Even if it succeeds in court, Revlimid will face limited-volume generic competition beginning in 2023.

But there are also a lot of positives for Celgene. You can start with the fact that sales for Revlimid continue to grow. Market research company EvaluatePharma projects that it will still rank as one of the world's top five best-selling blockbusters in 2024. 

Celgene's lineup includes several other blockbuster drugs as well. Sales for multiple myeloma drug Pomalyst and immunology drug Otezla continue to soar. Cancer drug Abraxane also is delivering solid single-digit percentage sales growth.

Probably the best thing going for Celgene, though, is its pipeline. The biotech expects to have five new drugs approved by 2020 that all have blockbuster potential -- multiple sclerosis drug ozanimod, myelofibrosis drug fedratinib, cell therapies bb2121 and liso-cel, and blood disorder drug luspatercept.

Then there's Bristol-Myers' pending acquisition of Celgene. The proposed offer represents a nice premium over Celgene's current share price. Celgene shareholders would also receive a contingent value right that gives them even more cash if ozanimod, bb2121, and liso-cel receive FDA approval by specified dates.

Better buy

My view is that Celgene is the better buy. Amgen's dividend is nice, but the company faces some challenges in delivering strong growth with sales declining for several of its top drugs. On the other hand, buying Celgene now would give investors a quick profit if the Bristol-Myers deal goes through.

But what if the acquisition doesn't happen? I still think Celgene would be a winner over the long run. The biotech seems likely to reach a settlement in the Revlimid litigation, something it's already done in the past. Celgene's current products and its promising pipeline candidates should enable the company to grow sales and earnings well into the next decade. 

Saturday, February 23, 2019

Friday’s Biggest Winners and Losers in the S&P 500

February 22, 2019: The S&P 500 closed up 0.6% at 2,792.65. The DJIA closed up 0.7% at 26,031.30. Separately, the Nasdaq closed up 0.9% at 7,527.54.

Friday was a positive day for the broad U.S. markets. Despite seeing some major stocks take a beating in this trading session, the broad markets pulled it out and posted a gain for the day, and ultimately the week. Crude oil inched forward in the session. The S&P 500 sectors were mostly positive. The most positive sectors were technology and health care up 1.0% and 0.8%, respectively. The worst performing sectors were consumer staples and finance, down 0.7% and 0.3%, respectively.

Crude oil was last seen up 0.4% at $57.18.

Gold was last seen trading flat at $1,330.50.

The S&P 500 stock posting the largest daily percentage loss ahead of the close was The Kraft Heinz Co. (NASDAQ: KHC) which traded down about 27.5% at $34.88. The stock's 52-week range is $34.51 to $70.01. Volume was about 134 million compared to the daily average volume of 6.6 million.

The S&P 500 stock posting the largest daily percentage gain in the S&P 500 ahead of the close was Intuit Inc. (NASDAQ: INTU) which rose by about 7% to $250.94. The stock's 52-week range is $162.59 to $251.57. Volume was about 3 million compared to the daily average volume of 1.7 million.

Thursday, February 21, 2019

Best High Tech Stocks To Watch For 2019

tags:XPO,ENVA,PSX,

Shares of Sensus Healthcare Inc (NASDAQ:SRTS) have earned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have covered the stock in the last year is $12.25.

Several brokerages have recently issued reports on SRTS. Maxim Group raised their target price on Sensus Healthcare from $9.00 to $10.00 and gave the company a “buy” rating in a research report on Wednesday, September 19th. HC Wainwright began coverage on Sensus Healthcare in a research report on Monday, August 27th. They set a “buy” rating and a $14.00 target price for the company. Roth Capital began coverage on Sensus Healthcare in a research report on Wednesday, August 1st. They set a “buy” rating and a $12.50 target price for the company. began coverage on Sensus Healthcare in a research report on Friday, July 6th. They set a “buy” rating and a $12.25 target price for the company. Finally, B. Riley began coverage on Sensus Healthcare in a research report on Wednesday. They set a “buy” rating and a $12.50 target price for the company.

Best High Tech Stocks To Watch For 2019: Express-1 Expedited Solutions Inc.(XPO)

Advisors' Opinion:
  • [By Rich Duprey, Nicholas Rossolillo, and Maxx Chatsko]

    Yet finding the best stocks to buy and hold isn't easy. So to help get you started, we asked three Foolish investors to pick a growth stock that they believe investors would be wise to buy now and hold for the long term. Read on to learn why they like SunPower (NASDAQ:SPWR), salesforce.com (NYSE:CRM), and XPO Logistics (NYSE:XPO).

  • [By Rich Duprey, Daniel Miller, and Steve Symington]

    It will help you, too, and your children for that matter. So we asked three Motley Fool contributors for stocks that meet that description. They chose Tesla (NASDAQ:TSLA), iQiyi (NASDAQ:IQ), and XPO Logistics (NYSE:XPO). Read on to learn why your kids could one day have these stocks in their brag book.

  • [By ]

    In the Lightning Round, Cramer was bullish on Idexx Laboratories (IDXX) , XPO Logistics (XPO) , Diamondback Energy (FANG) and Illinois Tool Works (ITW) .

  • [By Jeremy Bowman]

    However, the clearest sign yet of Amazon's potential impact in the industry came from the recent earnings report from XPO Logistics (NYSE:XPO), one of the biggest global providers of freight and logistics services and the leader in last-mile delivery of heavy goods like furniture and appliances. In its fourth-quarter report, XPO slashed its 2019 guidance significantly, and its shares fell by double digits on the report. The culprit was "the impact of our largest customer substantially downsizing its business portfolio," according to CEO Brad Jacobs. Jacobs went on to explain on the earnings call that XPO would lose $600 million in annual business from this customer, who was reducing business by two-thirds.  

  • [By Daniel Miller]

    Unfortunately, there's no crystal ball for investors to see into the future -- otherwise investing would be so much easier. Predicting how businesses and trends will play out over the coming years can be difficult, but Activision Blizzard (NASDAQ:ATVI) and XPO Logistics (NYSE:XPO) seem well-positioned to thrive over the next decade. One is benefiting from a rise in esports, the other from ever-increasing e-commerce deliveries.

Best High Tech Stocks To Watch For 2019: Enova International, Inc.(ENVA)

Advisors' Opinion:
  • [By Logan Wallace]

    Shares of Enova International Inc (NYSE:ENVA) have received an average recommendation of “Buy” from the eight research firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $35.80.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Enova International (ENVA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Enova International (ENVA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Enova International (NYSE: ENVA) and Regional Management (NYSE:RM) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

  • [By Shane Hupp]

    Media stories about Enova International (NYSE:ENVA) have been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Enova International earned a news impact score of 0.17 on Accern’s scale. Accern also assigned news headlines about the credit services provider an impact score of 47.1141156093879 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Best High Tech Stocks To Watch For 2019: Phillips 66(PSX)

Advisors' Opinion:
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Phillips 66 (PSX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By John Bromels]

    When billionaire investor Warren Buffett buys, people take notice. When one of those investments ups its dividend by 14%, they take further notice. Those are two reasons why Phillips 66 (NYSE:PSX) has been getting a lot of attention lately. 

  • [By Joseph Griffin]

    Frontier Investment Mgmt Co. boosted its stake in shares of Phillips 66 (NYSE:PSX) by 8.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 6,267 shares of the oil and gas company’s stock after purchasing an additional 478 shares during the period. Frontier Investment Mgmt Co.’s holdings in Phillips 66 were worth $704,000 at the end of the most recent reporting period.

  • [By Motley Fool Transcribers]

    Phillips 66  (NYSE:PSX)Q4 2018 Earnings Conference CallFeb. 08, 2019, 12:00 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

Wednesday, February 20, 2019

Top 5 Heal Care Stocks To Invest In 2019

tags:FCCO,ABAX,ASYS,LEN.B,OPOF,

Betting on a stronger dollar has been one of the most punishing consensus trades of 2017.

But instead of backing away from it, the Wall Street investment banks that recommended this trade to their clients are advising them to hold the position, arguing that an aggressive Fed and President Donald Trump's looming tax-reform shakeup will soon trigger a turnaround.

Two of the world's largest currency dealers, Citigroup Inc. and Deutsche Bank, are advising their clients that the greenback will strengthen against the euro and yen, its two biggest rivals, during the coming years.

Top 5 Heal Care Stocks To Invest In 2019: First Community Corporation(FCCO)

Advisors' Opinion:
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on First Community (FCCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    First Community Co. (NASDAQ:FCCO) – Analysts at FIG Partners upped their Q3 2018 earnings estimates for shares of First Community in a research note issued on Thursday, July 19th. FIG Partners analyst B. Martin now forecasts that the bank will post earnings of $0.40 per share for the quarter, up from their previous forecast of $0.39. FIG Partners also issued estimates for First Community’s Q4 2018 earnings at $0.38 EPS, FY2018 earnings at $1.52 EPS, Q2 2019 earnings at $0.42 EPS, Q3 2019 earnings at $0.43 EPS, Q4 2019 earnings at $0.39 EPS and FY2019 earnings at $1.60 EPS.

  • [By Shane Hupp]

    First Community (NASDAQ:FCCO) issued its quarterly earnings data on Wednesday. The bank reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.04, Fidelity Earnings reports. The business had revenue of $11.17 million during the quarter, compared to the consensus estimate of $10.83 million. First Community had a net margin of 13.91% and a return on equity of 8.23%.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on First Community (FCCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on First Community (FCCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Invest In 2019: ABAXIS Inc.(ABAX)

Advisors' Opinion:
  • [By Lisa Levin] Gainers Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. 21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82. Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87. HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50 Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62. Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11. Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33. Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55. Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday. Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results. Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13. Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19. Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance. ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating. Biolinerx Ltd/S ADR (NASDAQ: BLRX)
  • [By Logan Wallace]

    Shares of Abaxis (NASDAQ:ABAX) have been assigned a consensus rating of “Hold” from the eleven research firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target among analysts that have covered the stock in the last year is $58.33.

  • [By Lisa Levin] Gainers Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million. Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results. Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. 21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33. Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27. Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating. PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat. NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399. Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643. Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16. Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results. GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results. The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results. Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Lisa Levin]

    Abaxis, Inc. (NASDAQ: ABAX) shares were also up, gaining 16 percent to $82.95. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.

  • [By Ethan Ryder]

    State Board of Administration of Florida Retirement System lowered its holdings in Abaxis (NASDAQ:ABAX) by 23.6% during the 1st quarter, Holdings Channel reports. The firm owned 12,411 shares of the medical research company’s stock after selling 3,824 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Abaxis were worth $876,000 at the end of the most recent reporting period.

Top 5 Heal Care Stocks To Invest In 2019: Amtech Systems Inc.(ASYS)

Advisors' Opinion:
  • [By Lisa Levin] Gainers Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing. Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study. Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook. Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital. TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy. Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance. ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating. Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011. InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS. Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy.. SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday. Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Lisa Levin] Gainers Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study. Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing. ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating. Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook. TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy. Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday. Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital. Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00. SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday. Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40. Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins. Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Stephan Byrd]

    SUMITOMO HEAVY/ADR (NASDAQ: ASYS) and Amtech Systems (NASDAQ:ASYS) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

  • [By Lisa Levin] Gainers The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance. WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast. Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39. Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results. ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings. Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million. Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results. Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results. VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71. Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results. Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results. Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results. Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739. Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69

Top 5 Heal Care Stocks To Invest In 2019: Lennar Corporation(LEN.B)

Advisors' Opinion:
  • [By Ethan Ryder]

    ValuEngine lowered shares of Lennar Co. Class B (NYSE:LEN.B) from a sell rating to a strong sell rating in a research report sent to investors on Friday morning.

Top 5 Heal Care Stocks To Invest In 2019: Old Point Financial Corporation(OPOF)

Advisors' Opinion:
  • [By Stephan Byrd]

    News coverage about Old Point Financial (NASDAQ:OPOF) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Old Point Financial earned a media sentiment score of 0.01 on Accern’s scale. Accern also assigned press coverage about the bank an impact score of 46.7121766894414 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Tuesday, February 19, 2019

Top 5 Stocks To Buy For 2019

tags:GOL,AZZ,LN,DGLY,ABIO,

U.K. airlines’ practice of charging for assigned seats is being scrutinized by regulators amid concerns the policy -- which adds as much as 390 million pounds ($550 million) to ticket prices a year -- is confusing.

An increase in the number of complaints by passengers traveling in groups who are forced to pay to sit together has prompted an examination of “whether consumers are being treated fairly, and whether pricing policies are transparent,” the U.K. Civil Aviation Authority said Saturday in a statement.

#lazy-img-225281916:before{padding-top:66.675%;}

Andrew Haines

Photographer: Matthew Lloyd/Bloomberg

“Airline seating practices are clearly causing some confusion for consumers,” said Andrew Haines, chief executive officer of the CAA. “Our research shows that some consumers are paying to sit together when, in fact, they might not need to.”

Top 5 Stocks To Buy For 2019: Gol Linhas Aereas Inteligentes S.A.(GOL)

Advisors' Opinion:
  • [By Max Byerly]

    Get a free copy of the Zacks research report on Gol Linhas Aereas Inteligentes (GOL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Gol Linhas Aereas Inteligentes SA (NYSE:GOL) has received an average rating of “Hold” from the six analysts that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $8.67.

  • [By Logan Wallace]

    Gol Linhas Aereas Inteligentes SA (NYSE:GOL) has received an average recommendation of “Hold” from the seven analysts that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and four have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $8.67.

  • [By Max Byerly]

    Gol Transportes Aéreos (NYSE:GOL) shares traded down 5.4% on Monday . The company traded as low as $9.72 and last traded at $9.75. 524,965 shares traded hands during mid-day trading, an increase of 40% from the average session volume of 374,811 shares. The stock had previously closed at $10.31.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Gol Linhas Aereas Inteligentes (GOL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    COPYRIGHT VIOLATION WARNING: “Gol Linhas Aereas Inteligentes (GOL) Reaches New 12-Month High at $14.62” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/4125675/gol-linhas-aereas-inteligentes-gol-reaches-new-12-month-high-at-14-62.html.

Top 5 Stocks To Buy For 2019: AZZ Inc.(AZZ)

Advisors' Opinion:
  • [By Jim Crumly]

    As for individual stocks, Home Depot (NYSE:HD) slipped on a sales miss and AZZ (NYSE:AZZ) finally closed the books on a tough year.

    Image source: Getty Images.

  • [By Garrett Baldwin]

    Well, Money Morning Special Situations Strategist Tim Melvin has broken these secrets out of the vault of the Smart Money managers. And he's sharing the Max Wealth secrets for free right here.

    The Top Stock Market Stories for Tuesday In addition to slashing its global growth forecast, the IMF also cut expectations for the economies of Argentina, Brazil, Mexico, Iran, and Turkey. Emerging economies are facing higher capital outflows, rising interest rates, and increased debt pressures. The ongoing rise of the U.S. dollar has raised the borrowing costs of emerging markets as their currencies depreciated against the greenback. The IMF also had said America's international trade policies could slow global growth by an additional 0.8% in 2020. Italian populists are raising red flags over the new coalition government's 2019 budget and expected deficit targets. The government has said that it will target a 2.4% GDP deficit next year, followed by declines to 2.1% and 1.8% in 2020 and 2021, respectively. Italian bonds surged to their highest levels since 2014. U.S. President Donald Trump is expected to fulfill a campaign promise to eliminate a ban on ethanol blending during summer driving season. The policy is aimed at providing a boost to Corn Belt Republicans, who are facing tight Congressional races. Trump's ongoing trade battle with China and Europe has suppressed corn and soybean prices due to China's retaliatory tariffs on U.S. agricultural commodities. Stocks to Watch Today: PZZA, FB, GOOGL This morning, shares of Papa John's International Inc. (NASDAQ: PZZA) jumped 12% on speculation that a major hedge fund could buy more than just a slice of the company. Multiple reports indicate that Trian Fund Management is considering a bid to purchase the company. The company remains in a massive spat after booting its founder and former CEO John Schnatter, who was ousted earlier this year after making controversial statements during a conference call. Schnatter
  • [By Lisa Levin]

     

    Losers Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results. Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results. SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss. Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday. Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million. Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday. ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today. ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79. Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss. Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss. iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results. Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97. Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15. AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings. Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49. Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday. Myomo, Inc. (NYSE: MYO) slipp
  • [By Motley Fool Transcription]

    AZZ Inc. (NYSE:AZZ)Q2 2019 Earnings Conference CallOct. 9, 2018, 11:00 a.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Victory Capital Management Inc. boosted its stake in shares of AZZ Inc (NYSE:AZZ) by 0.2% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 729,371 shares of the industrial products company’s stock after buying an additional 1,584 shares during the period. Victory Capital Management Inc.’s holdings in AZZ were worth $31,691,000 as of its most recent SEC filing.

Top 5 Stocks To Buy For 2019: LINE Corporation (LN)

Advisors' Opinion:
  • [By Ethan Ryder]

    Headlines about Line (NYSE:LN) have been trending somewhat positive on Tuesday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Line earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned media stories about the technology company an impact score of 47.2836347777767 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By ]

    But as platforms such as Line (LN) and Tencent's (TCEHY) WeChat show, Messenger and WhatsApp each have tremendous potential to be monetized through some mixture of ads, payments, e-commerce services and in-app transactions. WeChat, which just topped 1 billion MAUs, is believed to have accounted for a healthy portion of the $36.4 billion in revenue Tencent produced last year. Line, which had 168 million MAUs at the end of last year, had 2017 revenue of 167 billion yen ($1.56 billion).

  • [By Ethan Ryder]

    Line (NYSE:LN) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday.

  • [By Ethan Ryder]

    Line (NYSE:LN) and HealthStream (NASDAQ:HSTM) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, profitability and analyst recommendations.

Top 5 Stocks To Buy For 2019: Digital Ally Inc.(DGLY)

Advisors' Opinion:
  • [By Logan Wallace]

    Digital Ally (NASDAQ:DGLY)‘s stock had its “buy” rating reiterated by equities research analysts at Westpark Capital in a research note issued on Wednesday. They currently have a $5.00 target price on the scientific and technical instruments company’s stock. Westpark Capital’s price objective indicates a potential upside of 17.65% from the company’s current price.

  • [By Max Byerly]

    Press coverage about Digital Ally (NASDAQ:DGLY) has trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Digital Ally earned a media sentiment score of 0.03 on Accern’s scale. Accern also assigned news coverage about the scientific and technical instruments company an impact score of 45.1932077082068 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Max Byerly]

    Digital Ally (NASDAQ:DGLY) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday.

Top 5 Stocks To Buy For 2019: Arca Biopharma Inc.(ABIO)

Advisors' Opinion:
  • [By Paul Ausick]

    ARCA biopharma Inc. (NASDAQ: ABIO) traded down nearly 80% Monday and posted a new 52-week low of $0.45 after closing Friday at $1.60. The stock’s 52-week high is $2.76. Volume was around 9 million, nearly 40 times the daily average of around 230,000. The company reported a poor result on a phase 2 trial of treatment for a certain kind of heart problem.

Monday, February 18, 2019

Accumulate Dr. Lal PathLabs; target of Rs 1070: Prabhudas Lilladher


Prabhudas Lilladher's research report on Dr. Lal PathLabs


DLPL's revenue, adj. EBITDA and PAT grew 11%, 16% and 27% YoY respectively in Q3FY19 and in line with our estimates in margin and earnings. With strong cash flow and growth in new customers and packaged offer, the company expects to maintain current growth in FY20E. The expansion of bundle-test offer and gradual ramp up of central lab in Kolkata (KRL) to improve further volume addition in FY20E and FY21E. Management expects competitive intensity to remain strong with price war, regulatory interference and expected price ceiling of government. DLPL remain confident of its brand power, service quality, high-end test capability, network of collection centers and KRL to drive volume growth and profitability in FY18-20E.


Outlook


We maintain "Accumulate" and move forward our base of valuation to 35x of FY21E earnings estimates to derive new TP at Rs1,070.


For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More First Published on Feb 18, 2019 02:11 pm

Sunday, February 17, 2019

Watsco (WSO) Q4 2018 Earnings Conference Call Transcript

Logo of jester cap with thought bubble with words 'Fool Transcripts' below it

Image source: The Motley Fool.

Watsco (NYSE:WSO) Q4 2018 Earnings Conference CallFeb. 14, 2019 10:00 a.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Good morning. Welcome to the Watsco fourth-quarter 2018 earnings conference call. [Operator instructions] Please note, this event is being recorded. I would now like to turn the conference over to Mr.

Al Nahmad, CEO. Please go ahead.

Al Nahmad -- Chief Executive Officer

Good morning, everyone. Welcome to our first quarter conference call. This is Al Nahmad, chairman and CEO, and with me is A.J. Nahmad, president; Paul Johnston, executive vice president; and Barry Logan, senior vice president.

As we always do, before we start, the usual cautionary statement. This conference call has forward-looking statements as defined by SEC laws and regulations that are made pursuant to the safe harbor provisions of these various laws. Ultimate results may differ materially from the forward-looking statements. 2018 was another record performance year with sales, operating profit, net income and EPS, all reaching new highs.

2018 also represents a milestone, marking Watsco's 30-year anniversary in distribution of HVAC. If we reflect for a moment on our distribution history, we have accomplished much as evidenced by gaining the industry leadership position, while generating a 30-year compounded total shareholder return of 18%. I'd like to repeat that, we've gained the industry leadership position and we've been producing 18% compounded returns for our shareholders for those 30 years. While that is a heck of an accomplishment, we passionately believe Watsco is still very much a work in process.

Substantial room to grow exists, given our moderate share in the $35 billion North American market. Great family businesses exist in this industry, many of which were found more than 20 years ago. It'd be very satisfied to associate with more of them and sustain the legacy as part of Watsco. We also have strong OEM relationships and in many cases, I would say, in most cases, Watsco is the OEM's largest customers.

We also believe that we still are far from reaching our full potential and scale with our OEM partners. Furthermore, in recent years, we have developed a culture of innovation and have launched a number of technologies for the benefit of our customers. In terms of adoption and scale of these technologies, we are only partly there and have yet to realize long-term benefits that we believe are possible. Our leadership team is filled with pounded ambitious people that have long-term equity to drive performance over the span of their careers.

And I consider this most important, our balance sheet remains pristine and allows for almost any sized investment. On to the year, 2018, it was a record year with success in many markets and challenges in many other markets. On balance, it was another solid year of growth, while continuing to invest in technology as well as in our organization. Our first release -- I'm sorry, our press release provides important details about Watsco's 2018 performance, including a summary of important technology metrics that might highlight our progress.

I really would encourage reading that press release. It's a very thorough report on much that's going on in the company. I will not recite these details in my prepared remarks, but we will be happy to provide more color during Q&A. One last thing I will add is an invitation to visit Miami and spend time with us to learn more.

We want to be accessible and informative to those that are interested, not to mention the fact that Miami is a great place to visit. With that, A.J., Paul, Barry and I are happy to answer your questions. 

Questions and Answers:

Operator

[Operator instructions] Our first question comes from Robert Barry with Buckingham Research. Please go ahead.

Al Nahmad -- Chief Executive Officer

Good morning, Robert.

Robert Barry -- Buckingham Research -- Analyst

Hey, guys. Good morning. Congrats on the 30-year anniversary.

Al Nahmad -- Chief Executive Officer

Thank you. Feels good.

Robert Barry -- Buckingham Research -- Analyst

So I'm just trying to think about the growth rate going forward here, I mean, given what's happening in Florida and, I guess, Latin America too. Do you think this 3% growth you posted in the quarter is kind of how we should think about where the business will be growing, at least in the kind of near to medium term?

Al Nahmad -- Chief Executive Officer

See I hope not, and we certainly don't think that way.

Robert Barry -- Buckingham Research -- Analyst

I mean, it sounds like...

Al Nahmad -- Chief Executive Officer

I mean, these markets change from time to time, and the only thing we've found over the last 30 years is that we're steady. Sometimes we grow at a faster rate than in other times, but we always grow. But I wouldn't be happy with 3% growth rate in revenue.

Robert Barry -- Buckingham Research -- Analyst

Yes. I mean, is there any release insight on the pressures that you're facing in Florida?

Al Nahmad -- Chief Executive Officer

Mr. Johnston?

Paul Johnston -- Executive Vice President

I don't. The pressures we feel in Florida is just -- there was a slight slowdown last year toward the second half of the year. Obviously, 6 months does not make a trend for Florida. It's going to be hot in Florida this summer, and our full expectation is that we're going to recover what -- Florida will recover, and our sales will grow again.

Robert Barry -- Buckingham Research -- Analyst

Yes. In 2019, I mean, what do you think would cause it to improve? It seems like it was down double digits in the quarter.

Paul Johnston -- Executive Vice President

In which quarter, Robert? Absolutely not, no way.

Al Nahmad -- Chief Executive Officer

No.

Robert Barry -- Buckingham Research -- Analyst

Yes. I was just -- rough math, it seems like the business grew three or seven times Florida. I don't know exactly what percent it is of the business, but I mean, big picture, I guess. It's causing some real pressure, and I'm just curious what you think would cause the pressure to alleviate.

Al Nahmad -- Chief Executive Officer

I don't know, I think we've asked it there.

Paul Johnston -- Executive Vice President

Yes, I just think it's going to -- we went into a slight downturn in the state of Florida in the second half of 2018, and it's our expectation that we think it will try to normalize again in 2019, and we'll grow our market share again, as we always have in Florida. For us, it wasn't a market share issue. It was a market issue.

Al Nahmad -- Chief Executive Officer

Not only that. When we first started, we were primarily a Florida business, and we knew there were risks in focusing on one geographic area. In order to produce steady results, we decided and very actively extended our distribution throughout the nation. So sometimes, you'll have soft markets in part of the nation.

Sometimes you'll have strong markets, that's what happened to us this time. So I feel very confident that because we are diversified in geography, that we'll just be a steady grower in a steady strong market.

Robert Barry -- Buckingham Research -- Analyst

Got it, got it. I guess, my other question...

Barry Logan -- Senior Vice President

Robert, I just want to -- Robert, it's Barry. I just want to clean this up, so we're clear. There certainly was growth in Florida in 2018, and as Paul suggested, the second half then equaled the first half in terms of growth rates and that slowness affected earnings because the infrastructure is built at a higher level and that can be addressed. Latin American markets are the one that had sales declines in 2018 and an earnings decline after really 4, 5 years of pretty incredible growth.

And so that team has the same task, reacting and -- to market conditions, reacting with SG&A and reacting with market share and moving forward. But -- so I'll make it very clear about growth in Florida this year.

Robert Barry -- Buckingham Research -- Analyst

OK, OK. I guess, my other question is really just on the SG&A performance, seeing that grow above the rate of sales are close to it. Just curious what the goal is there? I know you had spoken about 250 excess headcount that you're going to try and work down. Curious where that stands and just what the expectation is around the SG&A growth going forward.

Al Nahmad -- Chief Executive Officer

Barry?

Barry Logan -- Senior Vice President

Well, again, Robert, the concept was during this technology phase over the last few years was to have our team in the field, prepare and do and execute and prosecute all the stuff as they saw fit, and they did add headcount throughout that period of time and -- the technology headcount plus the 250 people you're talking about. So now the challenge is make something of it. It's not cutting headcount, it's not reducing the workforce. It's asking our leadership to go back out in our 2019 execution and plans to make hay out of those investments as well as be wise about growth versus SG&A growth.

So we've done that. We've asked for that. They've produced plans. We're comfortable going into 2019.

That'll be a better spread between sales and SG&A. In February, we're not going to project that out for a full year because the market really shook for us, shows up in spring and summer, but those plans have been laid for 2019.

Robert Barry -- Buckingham Research -- Analyst

Got it. Thank you.

Barry Logan -- Senior Vice President

Sure.

Operator

The next question comes from Brett Linzey with Vertical Research Partners. Please go ahead.

Al Nahmad -- Chief Executive Officer

Good morning, Brett.

Brett Linzey -- Vertical Research Partners -- Analyst

Good morning, guys. Just wanted to follow back up with the Florida and Latin America. So just to be clear, so Florida did not decline in Q4. It was all just a Latin America issue.

Is that correct?

Al Nahmad -- Chief Executive Officer

That's correct. Yes, that's correct.

Brett Linzey -- Vertical Research Partners -- Analyst

OK. And could you maybe size how large Florida and Latin America are as a percent of sales? And then, I guess, the follow on to that is, what really is the root cause there? Are you seeing increased bridge coverage from competitors in those particular regions? And then any sense as to what the markets did in the quarter?

Al Nahmad -- Chief Executive Officer

Barry?

Barry Logan -- Senior Vice President

Well, there's a lot there in the question. So we'll focus on Florida. About 20% of our locations are in Florida. So if you want to impute something, you can probably use that as a baseline, number one, which would make it approaching $1 billion business.

And obviously, if you look at any competitor in our market in Florida, there's nothing that's closed that I think is going to irritate market share to the extent that anyone might wish. And as Paul just said, a point blank, we did gain share in Florida, we can see the industry data, we know our unit data and are comfortable of saying that. So it is a market issue. In the second half, that simply needs to be reacted to.

And Latin American markets, again, I think our 10-K breaks out some of our foreign operations as percentages. It's in probably the 4% to 5% range. You can look at the 10-K and verify that and validate that. It is a profitable market and, again, has been growing exceptionally well over the last few years, and as it -- it's part Mexican politics in terms of the elections and I think now that, that's been settled, that's something that our team can move forward on with knowledge and what they're doing.

And we also have a weaker U.S. dollar in some of these markets, that makes our products more expensive in those markets. And again, that's a reaction that OEM and distributor and customer and our teams react to in those markets.

Brett Linzey -- Vertical Research Partners -- Analyst

OK. Yes, I appreciate that color. And then just in terms of the field-level incentive comp for 2018, a bit of a headwind here in Q4. What was the total spend for 2018? And does that continue into '19 as an incremental spending headwind?

Al Nahmad -- Chief Executive Officer

All yours, Barry.

Barry Logan -- Senior Vice President

All right. Well, again, it is a pay-for-performance culture, and when we talk about incentive pay, at the field level, it starts with 570 branch managers, it starts with their teams, their regional managers and their leaders in the markets. There's about 30 such divisions that operate P&Ls within Watsco. And many of those 30 had very good years versus last year, and many of those 30 have earned and been paid incentive compensation in excess of last year.

So that's really a scorecard on how well much of the company did this year versus last year, and we've given you some insight into the data behind that. So it's simply that pay-for-performance being better this year in many of those regions. And for next year, 2019, I hope all 30 hit their budget, I hope all 30 have incremental incentive pay, I hope all 30 reach those targets because it'll be good for Watsco. But obviously, in '18, you see a couple large penalties in two big markets for us, and -- but that doesn't mean the rest of the company didn't deserve and earn and get paid more incentive comp.

Brett Linzey -- Vertical Research Partners -- Analyst

OK. So all the catch-up was basically in 2018, and nothing else is expected in 2019 until you've kind of preferred out. Is that the right way to think about it?

Al Nahmad -- Chief Executive Officer

They must grow EBIT, they must generate cash flow to earn and the answer is yes.

Barry Logan -- Senior Vice President

Yes, the answer is yes.

Brett Linzey -- Vertical Research Partners -- Analyst

OK. Great. I appreciate it guys.

Al Nahmad -- Chief Executive Officer

You bet.

Operator

The next question is from Ryan Merkel with William Blair. Please go ahead.

Al Nahmad -- Chief Executive Officer

Good morning, Ryan.

Ryan Merkel -- William Blair -- Analyst

Hey, good morning, everyone. I'm sorry, to ask more Florida questions, but just want to be clear here, OK. It is your biggest market. So did trend sort of level out and stabilize in the fourth quarter? Is that the read here?

Al Nahmad -- Chief Executive Officer

Barry -- Paul?

Paul Johnston -- Executive Vice President

Yes, sure. Yes, in the fourth quarter, we did see a pickup in the quarter, which brought Florida overall as a market for the year, at about even to 2018. So yes.

Ryan Merkel -- William Blair -- Analyst

OK. So things are getting worse potentially stabilizing. Can you comment on, was the whole state of Florida week, because I'd heard it was mostly South Florida? Can you just comment there?

Paul Johnston -- Executive Vice President

While we don't have that level of expertise to be able to give you that, I don't think. It was a pretty much across the board in Florida, weakness that we saw in the fourth quarter, maybe a little bit stronger in the north, but not a big move. I mean, it was -- the downturn wasn't that severe. We just had a very small downtick, which we haven't experienced in several years.

Ryan Merkel -- William Blair -- Analyst

And you don't view this as a leading indicator for the rest of the HVAC industry at this time?

Paul Johnston -- Executive Vice President

For the rest of the HVAC industry at this time, I would say, no. I think, in most areas of the country, we're still seeing a buoyancy from the replacement market, that's going to continue to grow. We have good analytics, and we use our analytics internally for our strategy sessions, and we feel pretty good.

Ryan Merkel -- William Blair -- Analyst

OK. And just secondly, you mentioned growth initiatives, you're initiating with supplier health to take share. Can you just expand upon that a little bit?

Paul Johnston -- Executive Vice President

Those are -- really those are our best kept secrets until we launch them. And it's just not something that we want to present out. I'll be glad to talk about them at the end of the second quarter -- at the second quarter call because by that time, we'll have implemented them and they'll be out in the field.

Operator

The next question is from Stephen Volkmann with Jefferies LLC. Please go ahead.

Al Nahmad -- Chief Executive Officer

Hello?

Operator

My apologies. A slight technical error. If Stephen Volkmann would mind getting back in the queue. I will put you on next.

Right now, we do have David Manthey on the podium from Baird.

Jeff Hammond -- KeyBanc Capital Markets -- Analyst

Hey, good morning.

Al Nahmad -- Chief Executive Officer

Hi, David Manthey. How you doing?

Operator

I apologize, Jeff Hammond is on the queue, KeyBanc Capital Markets.

Al Nahmad -- Chief Executive Officer

Good morning, Jeff. We'll get it right.

Jeff Hammond -- KeyBanc Capital Markets -- Analyst

Good morning. So I guess, looking more broadly, away from just the Florida and Latin America or maybe that simply answers the question, you can see that the HR and HARDI data better, but it just seems like that the industry data has been much more robust. On a unit basis even than your total growth, I imagine, you'd had some price in there. So I'm just -- as you kind of analyze market share shifts, what's kind of driving the apparent share loss?

Al Nahmad -- Chief Executive Officer

Did you hear that Paul, apparent share loss.

Paul Johnston -- Executive Vice President

Yes, I did. Apparent share loss, I don't go with that, Jeff, but I do have good data, looking at the entire country and, frankly, what we saw was a more normal growth rate in a lot of our smile states in the Sunbelt. When you got up into the Midwest up around the Cleveland area and Detroit, Michigan, Illinois, those states were up strong double digit. In fact, we saw some states in the Midwest up by 25% to 30%.

So those states that had, had a -- have a weather impact to them, grew faster this year. We saw a very strong sales throughout our Northeast and New England, parts of the...

Al Nahmad -- Chief Executive Officer

They're very smaller part of our overall picture.

Paul Johnston -- Executive Vice President

Yes, they just don't represent enough to overcome what we have in the Sunbelt. We've always been a very, very strong player in the Sunbelt, as you know. So I would characterize it as a year where you had -- you didn't have a flat growth rate across the board. So when you see the entire industry up X percent, it could be up 20%, 25% in some states and flat to down some in other states.

Jeff Hammond -- KeyBanc Capital Markets -- Analyst

OK. Just on free cash flow, it looks like working capital was pretty big use this year, inventories build. Can you just kind of speak to that around the inventory level?

Al Nahmad -- Chief Executive Officer

Barry?

Barry Logan -- Senior Vice President

Sure. There was just two things, Jeff. Obviously, the units that we own at the end of this year are at a high price, so that would drive some inventory investment. Also coming into this year, we would -- we did decide to use our balance sheet and bought some products at the closing bell, so to speak, in December that averts a price increase heading into 2019.

So that lets us have some either profit or competitiveness in our pocket going into 2019. And so that's the inventory story. There's also a tax story, which we explained in the press release of the timing of tax payments between last year and this year. That's about $100 million swing in working capital, if you compare year over year, and that's just really something that happened in 2017 from the hurricanes that didn't recur in 2018.

So moving forward, cash flow will not have any influence like that. And if we work inventory down from this point, which we expect to for the rest of the year, this is going to be a strong cash flow year.

Jeff Hammond -- KeyBanc Capital Markets -- Analyst

OK. And then if I could can just fit, one last one. Barry, can you just kind of reexplain the nonvested restricted stock lifeline item, it seems like it kind of -- if you sum it for the fourth quarter, is it doesn't equal the year? And I know that kind of swings the kind of full-year EPS a little bit. If you could just help us understand that?

Barry Logan -- Senior Vice President

Yes. So, again, this is Barry, the accountant for a second, Jeff. So I appreciate it. I appreciate being able to do this for you.

Restricted stock, obviously, is a percentage of our outstanding common stock and the accounting for the restricted stock is really done through the EPS line. The numerator simply as a matter of -- for EPS is, it takes our income, subtracts what's allocable to restricted shares, and that's the numerator for net income and EPS. But if there is a quarter, where our cash dividend exceeds earnings, that is also accounted for in the numerator for EPS. So a quarter like we are just in, where our dividend rate exceeded our EPS rate, there's a small -- there's a $0.03 hit in that quarter for that impact.

It doesn't affect the year, it doesn't affect the first half of the year. It just affects quarters. That algebra affects quarters, where that's the case. So that doesn't make any sense to you at all.

I can explain it again, but what I want to say is this, in the first quarter of 2019, where our dividend rate is now $1.60 compared to, we feel like what consensus EPS is, for example, the dividend in the first quarter will exceed that and we'll have to do the algebra. And when you build a model, you'll have to do the algebra for that. Just for the quarter, it does not impact the full year. So again, feel free to call me back and we can go through it, but it's something that has to be carefully modeled in, in the first quarter, as we head into 2019.

Jeff Hammond -- KeyBanc Capital Markets -- Analyst

OK. Thanks, Barry.

Operator

The next question is from Stephen Volkmann with Jefferies LLC. Please go ahead.

Al Nahmad -- Chief Executive Officer

Hi, Steve.

Stephen Volkmann -- Jefferies LLC -- Analyst

Good morning. Good morning, guys. Can you hear me this time?

Al Nahmad -- Chief Executive Officer

Perfectly.

Stephen Volkmann -- Jefferies LLC -- Analyst

All right. Great. It's always fun to be speaking out into the ether with nobody there, but anyway, thanks for looping me back in. Couple of quick things.

Barry, I think, you mentioned a couple of times, I just want to make sure I understood this correctly that you have plans setup to sort of size the business sort of react accordingly relative to what you're seeing in places like Florida and Latin America. And I'm just curious if you can expand on that a little bit? I think you mentioned something about gaining share, but is there something to do on the cost side as well? And should we be modeling? Maybe some slight declines in SG&A or something as a result of this?

Barry Logan -- Senior Vice President

Well, again, let's talk about culture to answer it initially, and the answer is yes, though we expect that in these markets that our leadership react on the cost side because that's how you can help grow earnings. The more definite opportunity is to grow sales and then make hay during that type of a period. And really use these conditions to fire things up and gain share. So both are going on.

It's not one or the other, it's absolutely both. So in terms of materiality to the whole picture in 2019, I think, culturally, again, we're pushing for better SG&A performance, just in general, and in these specific markets, probably, the efforts will be that much more. But this is a really universal kind of leadership challenge we've put out across the 30 business units and having the culture react to the conditions and not to cease individual markets.

Stephen Volkmann -- Jefferies LLC -- Analyst

OK, great. And then maybe if I can just switch to some of your technology investments. I think you said in the release something like 30% of your business is going through your digital platforms. I think I heard that right, and I'm curious -- I'm sure that's a rounded number, but I'm curious how that sort of trended through 2018, and what type of curve you think we should think about going forward? And maybe as a quick follow on, I'm guessing it's probably a lesser number of your overall customers, who actually do more business with you.

So just, I guess, I'm trying to get to is, are you satisfied with the takeup at the customer level? Is there more you could be doing to shift people in this direction? And just any commentary around that?

Barry Logan -- Senior Vice President

Well, I'd say that there's no question. We're doing -- we're going to do more. The trend is certainly there, and we're going to -- it's such a great digital platform, we're going to be very focused on going to e-commerce. It's -- no one can do that much -- as much good as we do with it.

The information that we provide, when you -- along with e-commerce, what we call the PIM, Product Information Master. So it's a very valuable tool for our contractors, and that again we certainly expect further and further adoption. Wish I can say, it's all going to be adopted in next number of months or years, but it's just had to say. But I think, it's such a useful tool for contractors, and we are so passionate about helping our contractors that we're just going to continue to improve the technology they have and teach them how to use it and be their partners in the learning curve.

So the answer is, yes, expect growth to be under 30%.

Stephen Volkmann -- Jefferies LLC -- Analyst

Has your uptake been slower than you might have hoped for?

Barry Logan -- Senior Vice President

These are all new. I can make up a story, but I just don't do things like that. We don't know. We just went up and did this.

Nobody's done this in our industry to the scale, but we have. And we're very happy. I mean, we started this, what was it, A.J., 4 years ago.

Al Nahmad -- Chief Executive Officer

Right.

Barry Logan -- Senior Vice President

And now we're $1.2 billion, about $4.5 billion business. I mean, it's satisfying, it's gratifying. Do I think it's a great service to the contractor? We absolutely believe that. Do I think we're going to have much more adoption of it? Yes.

Again, I'm going to tell you when that's going to occur. You guys asked those questions and we try to answer them, but we really don't know. But if the trend is followed, it's going really good.

Stephen Volkmann -- Jefferies LLC -- Analyst

OK. I appreciate the color and maybe, Barry, is there any meaningful change in spending on these things going forward in 2019 versus '18?

Al Nahmad -- Chief Executive Officer

Well -- go ahead, Barry. Sorry.

Barry Logan -- Senior Vice President

Go ahead, A.J.

Al Nahmad -- Chief Executive Officer

Maybe I can give some context, since we're talking technology. So first, we've said from the beginning that we're a long-term company and this a long-term program to really modernize our business. It's not just technology. It's people, process, technology and being competitive in 2019 and for the next 20-plus years, 30-plus years.

So this has been a very deliberate and very important process for us. We've been very cautious in our approach. We've been risk-averse in how we do this. We're OK taking our time and trying to get it right.

And over the last 4 or 5 years, really what we've done is reestablished a foundation of who we are as a business and what our capabilities are, right? Business intelligence, data analytics, e-commerce that you mentioned, product information management, where we now have 800,000 or so SKUs and that's in our database, our contractor apps, our apps in our warehouses. These are all platforms that have all gone through a cycle of due diligence and design and development and essentially rollout and now adoption. And again, there's been serious adoption of some of these tools, right? We have 2,000 people using our business intelligence tools. We've got 30% of our sales online.

To your point earlier, that's about 15,000 contractors using this tool. We've got almost 100,000 contractors used our apps last year and over one million times. Even our ERPs are now on the latest version of software for the first time in a long time, and we've got a new web service API. I won't go down to technologies, but the point is that we've got this new foundation, that's kind of materialized that can put us in a position to do new things, right? Take our new technologies or modern technologies to modernize our core business processes to gain efficiencies, operations and warehouses, logistics, pricing, how we manage credit and payments, everything and along those lines and then it puts us in a position to take advantage of cutting edge, best-of-breed technologies to really help our customers and whether that's helped them gain efficiencies, bring them new products to sell, bring them new ways to sell products, new ways to grow their businesses.

But we've got these 15,000 customers buying online, 90,000 in total. These -- I guess, where we are in the life cycle of technology is we've now reestablished sort of our capabilities that and we're positioned to take advantage of more sales, more margins, lower cost-to-serve, all with a focus of helping our customers. And the customers feel that. And that's why they're buying more online, that's why the adoption rates are what they are and continue to tick up.

Stephen Volkmann -- Jefferies LLC -- Analyst

Great. Thank you. I will pass it on. I appreciate it.

Operator

If David Manthey still has a question for the speakers, please reenter the question queue. Next, we have Ronald Newman, a private investor. Please go ahead.

Al Nahmad -- Chief Executive Officer

A former employee?

Ronald Newman -- Private Investor -- Analyst

Al, Barry and A.J. I just -- I don't have a question. I'm just calling to congratulate you on the 30 years in the industry and the absolute amazing things you've done in it.

Al Nahmad -- Chief Executive Officer

Oh, that's nice, Ron. We miss you. How long you've been?

Ronald Newman -- Private Investor -- Analyst

Yes, it's been 20 years.

Al Nahmad -- Chief Executive Officer

20 years since you left, big changes. Yes.

Ronald Newman -- Private Investor -- Analyst

Yes. Anyway, I just wanted to -- I knew that I could get all of you at the same time on this call, that's why I joined in. I don't want to distract from the questions, but I just think it's great.

Al Nahmad -- Chief Executive Officer

Big hugs to your wife and your boy. He's not a boy now, he's a big man, I guess.

Ronald Newman -- Private Investor -- Analyst

45 years old. All right. Congratulations again. Bye bye.

Al Nahmad -- Chief Executive Officer

Thanks. Thank you very much.

Operator

The next question comes from Dave Manthey with Baird. Please go ahead.

Al Nahmad -- Chief Executive Officer

Hi, Dave.

Dave Manthey -- Robert W. Baird and Company -- Analyst

Hey, good morning. That's a tough act to follow there. But I'll bring it back to the questions about the quarter here. So first off, price mix has been very strong for you lately.

Can you give us an idea of what price mix contribution was in the fourth quarter? And then what your expectations would be for 2019, as you look at it right now?

Al Nahmad -- Chief Executive Officer

Who want that one, you Barry or Paul? Hello? Are you guys on the line? Are we blank again? No body is on? Hello?

Operator

It looks like everyone is still on.

Al Nahmad -- Chief Executive Officer

Yes, but they couldn't hear me. So I don't know what's going on. Barry, are you still on the phone?

Operator

They are still connected.

Al Nahmad -- Chief Executive Officer

No, madam, they are not connected. They're not hearing us.

Operator

Right.

Al Nahmad -- Chief Executive Officer

And we're not hearing them.

Operator

OK. Let me troubleshoot a moment.

Unknown Speaker

Well, while we're waiting, Al, let me add to the congratulations on 30 years.

Al Nahmad -- Chief Executive Officer

OK. Thanks very much. It's been a joy. But I'll tell you this, I'm more excited about the next 30 years than I am about the last 30 years.

This technology stuff is really a great way to embrace our customers in a way that very few can do. And I hope to be here another 30 years. How's that?

Unknown Speaker

That sounds good.

Al Nahmad -- Chief Executive Officer

I don't think we've ever had this kind of a technical breakdown before.

Operator

Right. We are rejoining Barry Logan to the conference and when he is back in, I'll let you know. We connected Barry Logan.

Al Nahmad -- Chief Executive Officer

Well, Barry, go ahead and answer his question, if you remember.

Barry Logan -- Senior Vice President

Yes, let's dial it back. And I think maybe I didn't hear the question.

Dave Manthey -- Robert W. Baird and Company -- Analyst

Yes, Barry, it's Dave Manthey here. My question was, price mix has clearly been very strong through lately. Any comments about what it was in the fourth quarter and then as you look to next year, would you still expect, I don't know, low to mid-single digit kind of positive contribution from price mix?

Barry Logan -- Senior Vice President

Yes, I think and I'd rather speak to the year than individual quarter, Dave, just to be a little careful about it, but it's been kind of in a mid-single digit price for most of the year. I think the fourth quarter is similar, and that's above average from any recent year or a normal year, I would say. So that would be a little more moderate heading into next year. And again, let me just say this also in the context of that.

If I take Florida out of the fourth quarter, our equipment business grew almost 9% in the quarter. So there are some real positives going on, part of that's units, part of its price for next year. I think it was something more normal based on what we're hearing and seeing so far. In February, it's still early, but that's what we see.

Dave Manthey -- Robert W. Baird and Company -- Analyst

Yes, it makes sense. And then second, about what percent was the international business down in the fourth quarter?

Barry Logan -- Senior Vice President

I'd rather not implicate that story anymore than we have, David. It's awesome. It's not a tsunami, it's just a business that has had great margin and in a short quarter like this, it has a bigger impact than normal.

Dave Manthey -- Robert W. Baird and Company -- Analyst

All right. You said it's about 4% to 5% of the annual sales and it's down double digits, maybe something like that.

Barry Logan -- Senior Vice President

You said it.

Dave Manthey -- Robert W. Baird and Company -- Analyst

All right. Well thanks very much for all the time guys.

Barry Logan -- Senior Vice President

Sure.

Al Nahmad -- Chief Executive Officer

Are you still there operator?

Operator

Yes. The next question comes from Blake Hirschman with Stephens Inc. Please go ahead.

Al Nahmad -- Chief Executive Officer

Hello, Blake.

Blake Hirschman -- Stephens Inc. -- Analyst

Hey, guys. First off, just on M&A. It's been kind of quiet, can you talk about the pipeline? I assume there's probably been a gap between buyer and seller expectations holding back deal flow, but with overall housing outlook having softened a bit, have you seen potential sellers returned to the table and become a little bit more or less when it comes to the market that they are asking for?

Al Nahmad -- Chief Executive Officer

Mr. Logan?

Barry Logan -- Senior Vice President

Yes, it's like I wish it was about money. It's usually not. It's really an emotional process and timing for a family and in terms of conversation. We would always try to meet what an owner's expectation might be in order to make them happy and reduce risk going into a deal and so then the real question is, is there anything for sale where our people's emotions and so on? And I can tell you two things.

We put much more effort into prying lose, prying open some of those discussions, and we're having some success. Secondly, we're using our technology story as an ingredient to that conversation, which, again, I think is helping bring some success to those discussions. So like the press release does intimate, we do like the conditions. There is some good activity.

I never want to jinx it by mentioning it or saying anything much about it, but we do like the conditions that we're in and there has been, I would say, better actions and reactions going on in that respect.

Blake Hirschman -- Stephens Inc. -- Analyst

Got it. And in the past, you've kind of talked about those three indicators of cycle health being margins, bed debt and mix. As of last quarter, sounded like all three were hanging in there all right. Is there any update to provide on those?

Barry Logan -- Senior Vice President

Well, mix, again, is an important one, and it's the -- I think the 25th straight quarter where we've seen improvement in mix and what that means, again, is the percentage growth rate of high-efficiency systems beyond the standards here. So that's a good benchmark what consumers are spending and investing in their products with our customer. From a bad debt point of view, past dues, and so on, again, one of the healthiest years we've had and certainly current trends are -- again, remain favorable. And then price and unit volume, if we're growing gross profit margin, which we did in the fourth quarter and the year, our equipment business even more so than optically what you can see in our financials, again, that speaks to the ability and capability of passing through price and gaining that.

So that is -- those are positives that remain.

Blake Hirschman -- Stephens Inc. -- Analyst

Got it. And then just lastly for me on the UTX split carrier, obviously, an important strategic partner of yours with the plan breakup now confirmed. Can you touch on some of the dynamics that play there and some of the more structural or bigger picture impact that would come as a result of them being a stand-alone entity?

Barry Logan -- Senior Vice President

Well, we listen very carefully to the UTX report to the public. Their CEO, Greg Hayes, I think, is very articulate why they're doing what they're doing and he also has gone further to say that a separate carrier means that there'll be more aggressive in pursuit of share market whereas as part of United Technologies, they were sustained -- they had sustain certain margins. He said such things. So I expect a much more aggressive carrier, and I think it's good for us, good for the industry, and we're going to be very strong partner of there's.

We're going to invest whatever is needed to continue to be the great partner. In terms of other stuff, like consolidation, it seems like that's proved out from what I know in terms of major OEMs emerging or being acquired by others.

Blake Hirschman -- Stephens Inc. -- Analyst

Got. I'll turn it over. Thanks.

Al Nahmad -- Chief Executive Officer

Operator, A.J. Nahmad is not connected.

Operator

OK. We will get him connected too. I apologize for that. It looks like -- he looks connected on already, so we'll disconnect him and reconnect him.

Al Nahmad -- Chief Executive Officer

OK. Next question, please?

Operator

The question comes from Jeff Hammond with KeyBanc Capital Markets.

Al Nahmad -- Chief Executive Officer

Hi, Jeff. Hello? Hello?

Operator

Jeff is on the podium. We have an operator who is working to get him back on.

Al Nahmad -- Chief Executive Officer

Barry, have you even seen something like this before. It's my first experience.

Barry Logan -- Senior Vice President

No.

Al Nahmad -- Chief Executive Officer

Are these new people?

Barry Logan -- Senior Vice President

No.

Operator

No. These are unusual circumstances. I do see that A.J. Nahmad is back in and Jeff...

Al Nahmad -- Chief Executive Officer

A.J., you on?

I am on, yes.

Yes. And Paul needs to be reconnected as well. Paul Johnston needs to be connected.

Operator

OK. He is being reconnected now. And, Jeff, can you hear the conference?

Al Nahmad -- Chief Executive Officer

Jeff Hammond?

Operator

OK. We'll get him reconnected as well. OK. Paul is back online with us.

And Jeff will be shortly.

Al Nahmad -- Chief Executive Officer

Jeff, are you on? He's not.

Operator

We are still reconnected him.

Al Nahmad -- Chief Executive Officer

Are there any other questions?

Operator

There are no other questions in the queue.

Al Nahmad -- Chief Executive Officer

Operator, are any others connected to this call?

Operator

I believe that everyone is connected still. No? Yes. Let's see. Everyone shows up on my end is in conference, except that Jeff Hammond is still idle.

And the operator is attempting to get him back on. We actually do have another person who has entered the queue. I'll put his question on the podium. This is Christopher Dankert with Longbow Research.

Please go ahead.

Unkown Speaker

Can you hear me?

Al Nahmad -- Chief Executive Officer

Yes. I'm sorry about all these problems. We've never had this happened in the past.

Unkown Speaker

Well, this is actually Carl on for Chris. So I could figure out, I just jumped in front of Jeff and you. I had a chance. So you kind of talked about gross margin improving in the fourth quarter, it sounded like.

Could you talk about maybe where price cost has started entering 2019?

Al Nahmad -- Chief Executive Officer

Barry?

Barry Logan -- Senior Vice President

Well, first, there were some fourth-quarter price increases that were implemented. And again, it speaks to how they pass through as gross profit did go up in the quarter. There are some first quarter price increases with some of our OEMs as well that play out more into February and March. Though again -- so maybe some moderate benefit and then our market test in April, May, June, but there is more price coming and not to the same extent, but I would say, a more normal pattern should happen this year and we'll know more when it plays out in the spring.

Unkown Speaker

Got it. Thanks. That's all I have.

Operator

OK. We do have Jeff Hammond. He is with KeyBanc Capital Markets.

Al Nahmad -- Chief Executive Officer

Jeff, hi. Are you there, Jeff? Hello?

Operator

Jeff, your line should be open. You are in talk and in the conference recording.

Al Nahmad -- Chief Executive Officer

Are there any other questions after this one?

Operator

There are no other questions at the...

Al Nahmad -- Chief Executive Officer

Barry, why don't you call Jeff? Jeff? Barry?

Barry Logan -- Senior Vice President

Yes. I'll call him.

Al Nahmad -- Chief Executive Officer

Call him, because who knows where this is going to end. And, operator, what can I say, this is probably the worst connectivity we've had in 40 years for our company calls.

Operator

I do apologize for this. I am not sure what...

Al Nahmad -- Chief Executive Officer

Well, it's not you who should apologize. It's the owner or the manager who has to know what this is going on. So, bye.

Operator

Right. And they will.

Al Nahmad -- Chief Executive Officer

Bye. Bye-bye.

Operator

[Operator signoff]

Duration: 51 minutes

Call Participants:

Al Nahmad -- Chief Executive Officer

Robert Barry -- Buckingham Research -- Analyst

Paul Johnston -- Executive Vice President

Barry Logan -- Senior Vice President

Brett Linzey -- Vertical Research Partners -- Analyst

Ryan Merkel -- William Blair -- Analyst

Jeff Hammond -- KeyBanc Capital Markets -- Analyst

Stephen Volkmann -- Jefferies LLC -- Analyst

Ronald Newman -- Private Investor -- Analyst

Dave Manthey -- Robert W. Baird and Company -- Analyst

Blake Hirschman -- Stephens Inc. -- Analyst

More WSO analysis

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

10 stocks we like better than WatscoWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Watsco wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of January 31, 2019

Saturday, February 16, 2019

2,900 Shares in Assurant, Inc. (AIZ) Acquired by Bailard Inc.

Bailard Inc. acquired a new position in Assurant, Inc. (NYSE:AIZ) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 2,900 shares of the financial services provider’s stock, valued at approximately $259,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in Assurant by 2.1% during the 3rd quarter. Vanguard Group Inc. now owns 5,653,635 shares of the financial services provider’s stock valued at $610,310,000 after purchasing an additional 113,694 shares during the last quarter. Vanguard Group Inc lifted its stake in shares of Assurant by 2.1% in the 3rd quarter. Vanguard Group Inc now owns 5,653,635 shares of the financial services provider’s stock worth $610,310,000 after purchasing an additional 113,694 shares during the period. FMR LLC lifted its stake in shares of Assurant by 0.4% in the 3rd quarter. FMR LLC now owns 3,966,505 shares of the financial services provider’s stock worth $428,185,000 after purchasing an additional 14,264 shares during the period. Bank of New York Mellon Corp raised its stake in Assurant by 56.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,611,053 shares of the financial services provider’s stock worth $166,729,000 after acquiring an additional 584,393 shares during the period. Finally, Massachusetts Financial Services Co. MA raised its stake in Assurant by 3.0% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 749,807 shares of the financial services provider’s stock worth $80,941,000 after acquiring an additional 21,903 shares during the period. 92.12% of the stock is owned by hedge funds and other institutional investors.

Get Assurant alerts:

In other Assurant news, EVP Christopher J. Pagano sold 1,250 shares of the company’s stock in a transaction that occurred on Monday, December 10th. The stock was sold at an average price of $90.17, for a total value of $112,712.50. Following the sale, the executive vice president now owns 53,423 shares in the company, valued at approximately $4,817,151.91. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.93% of the stock is owned by corporate insiders.

Separately, ValuEngine upgraded shares of Assurant from a “hold” rating to a “buy” rating in a research report on Saturday, November 10th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $128.75.

AIZ stock opened at $97.13 on Friday. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $6.13 billion, a P/E ratio of 24.40 and a beta of 0.61. Assurant, Inc. has a 1-year low of $82.31 and a 1-year high of $111.43.

Assurant (NYSE:AIZ) last announced its earnings results on Tuesday, February 12th. The financial services provider reported $0.77 EPS for the quarter, topping the Zacks’ consensus estimate of $0.46 by $0.31. Assurant had a net margin of 7.27% and a return on equity of 8.27%. The business had revenue of $2.32 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the previous year, the company posted $1.84 earnings per share. The firm’s revenue was up 38.2% on a year-over-year basis. On average, sell-side analysts anticipate that Assurant, Inc. will post 5.64 EPS for the current fiscal year.

Assurant declared that its board has approved a stock buyback plan on Monday, November 5th that permits the company to repurchase $600.00 million in shares. This repurchase authorization permits the financial services provider to purchase up to 9.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.

The company also recently announced a quarterly dividend, which will be paid on Monday, March 18th. Investors of record on Monday, February 25th will be given a $0.60 dividend. The ex-dividend date of this dividend is Friday, February 22nd. This represents a $2.40 dividend on an annualized basis and a yield of 2.47%. Assurant’s dividend payout ratio is currently 60.30%.

TRADEMARK VIOLATION WARNING: “2,900 Shares in Assurant, Inc. (AIZ) Acquired by Bailard Inc.” was published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/4153064/2900-shares-in-assurant-inc-aiz-acquired-by-bailard-inc.html.

Assurant Company Profile

Assurant, Inc, through its subsidiaries, provides risk management solutions for housing and lifestyle markets in North America, Latin America, Europe, and the Asia Pacific. The company operates through three segments: Global Housing, Global Lifestyle, and Global Preneed. Its Global Housing segment provides lender-placed homeowners, manufactured housing, and flood insurance; renters insurance and related products; and mortgage solutions comprising property inspection and preservation, valuation and title, and other property risk management services.

Further Reading: Why is the ROA ratio important?

Want to see what other hedge funds are holding AIZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Assurant, Inc. (NYSE:AIZ).

Institutional Ownership by Quarter for Assurant (NYSE:AIZ)